The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
TRULICITY dulaglutide (rch) 1.5 mg/0.5 mL solution for injection prefilled pen, Eli Lilly Australia Pty Ltd, CON-1240
Product name
TRULICITY dulaglutide (rch) 1.5 mg/0.5 mL solution for injection prefilled pen
Sponsor name
Eli Lilly Australia Pty Ltd
Consent start
Consent no.
CON-1240
Duration
The consent is effective from 20 May 2024 until 31 March 2025.
Standard
paragraph 8 (1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product(s) do not include the correct address for the sponsor, and say North
Ryde, NSW in place of Sydney, NSW
Therapeutic product type
Prescription medicines